---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-212159"
form_type: "8-K"
ticker: "STE"
cik: "0001757898"
company_name: "STERIS plc"
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:55:44.421388+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# STERIS appoints Pierre Boulud to board; Richard Breeden to retire at 2026 AGM

## Summary
- Richard C. Breeden notified he will not stand for reelection at 2026 AGM; retirement not due to any disagreement.
- Board increased from 9 to 10 members; Pierre Boulud appointed director effective May 5, 2026.
- Boulud is CEO of bioMérieux (in vitro diagnostics); previously COO at bioMérieux and exec at Ipsen.
- Boulud receives prorated fee of $76,989 in restricted stock units for remainder of board term.

## SEC filing metadata
- accession: 0001193125-26-212159
- form_type: 8-K
- ticker: STE
- cik: 0001757898
- company_name: STERIS plc
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757898/000119312526212159/0001193125-26-212159-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757898/000119312526212159/d27562d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-212159
- JSON: https://secwatch.observer/filing/0001193125-26-212159.json
- Plain text: https://secwatch.observer/filing/0001193125-26-212159.txt

## Key facts
- Executive change
  Richard C. Breeden departed as Director at STERIS plc.
  - Action: not stand for reelection
  - Role: Director
  source text: On May 1, 2026, Richard C. Breeden notified STERIS plc (the “Company”) that he will not stand for reelection to the Board of Directors (the “Board”) at the Company’s 2026 Annual General Meeting of Shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757898/000119312526212159/0001193125-26-212159-index.htm
- Executive change
  Pierre Boulud was appointed as Director at STERIS plc.
  - Action: appointed
  - Role: Director
  source text: On May 5, 2026, the Board of the Company increased its size from nine to ten members and appointed Pierre Boulud to serve as a director effective as of that date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757898/000119312526212159/0001193125-26-212159-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.